Hazard ratio (hazard ratio, higher-risk half against lower-risk half at the median predicted risk, progression-free survival, Cox stratified by treatment arm, Efron ties, full follow-up; equal-trial geometric mean over three trials) of Isoform TPM features (Ladon report) on Three held-out trials with progression-free survival
1.33 Hazard ratio (hazard ratio, higher-risk half against lower-risk half at the median predicted risk, progression-free survival, Cox stratified by treatment arm, Efron ties, full follow-up; equal-trial geometric mean over three trials)
Methods
- Tested method
- Isoform TPM features (Ladon report)
- Protocol
- Held-out trials, PFS hazard ratio of higher- against lower-risk half, geometric mean over three trials
- Dataset subset
- Three held-out trials with progression-free survival
- Procedure
- Held-out trials, PFS hazard ratio of higher- against lower-risk half, geometric mean over three trials
- Evaluation
- TPM · matched TCGA, held-out trials PFS hazard ratio
- Coverage
- 3/3 trials scored (All trials estimable.)
- Uncertainty
- Not reported by the source: Per-trial dots and a bar only; no interval is printed.
- Evidence
- Author-reported evaluation · source checkedLadon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 3 (page 7), row 'TPM · matched TCGA', label 'PFS 1.33'
A source-checked result verifies the numerical transcription, not every model or protocol detail. Evaluation metadata: source checked. Source checked does not mean independently reproduced.
Reproduction
- Split
- Held-out trial; predictor fitted on TCGA and the other trials
- Adaptation
- Isoform TPM, 100 principal components, elastic-net Cox fitted on cancer-matched TCGA cohorts (CPTAC lung for IMpower133)
- Scoring implementation
- Median split of predicted risk; unpenalised Cox with binary group indicator stratified by arm, Efron ties
No execution recipe has been verified for this exact configuration and evaluation. A benchmark's general instructions may use different inputs, splits or model settings.
Reproducing this published result requires matching its model configuration, data, split and scorer. Source checking or a successful smoke test does not establish score reproduction.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
1 evidence row matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|---|---|
| Reported result 1.33 Individual claims | Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) Figure 3 (page 7), row 'TPM · matched TCGA', label 'PFS 1.33' Version: Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026 | source checked ["independent-cell-check","pdf-text-parse","source-hash-verification"] · 2026-11-15T23:30:00Z author reported Audit detailsPrinted label re-read from the pinned PDF by coordinates; it matched. Field: Source artifact SHA-256: Hash scope: Hash scope not separately documented; inspect source record Extraction artifact SHA-256: |
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
1 source record and release history
- Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Original source · Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Technical metadata and extraction receipts
Stable ID: ladon-20261115-result-fig3-tpm-matched-tcga-pfs
- areas
- rna-transcriptomes
- contexts
- clinical_research
- coverage
- eligible: 3; note: All trials estimable.; scored: 3; unit: trials
- metric
- hazard-ratio
- metric direction
- higher
- metric qualifier
- hazard ratio, higher-risk half against lower-risk half at the median predicted risk, progression-free survival, Cox stratified by treatment arm, Efron ties, full follow-up; equal-trial geometric mean over three trials
- missing metadata
- uncertainty: note: Per-trial dots and a bar only; no interval is printed.; reason: unreported
- numeric value
- 1.33
- printed value
- 1.33
- review
- artifact sha256: 64edf7c3c956c50a65aa01a0dcaa13f0cfef28ab4373ecfd50c431e67143893c; method: independent-cell-check; pdf-text-parse; source-hash-verification; method note: Independent review pass. The Zenodo PDF was re-downloaded and its SHA-256 and MD5 checked against the source record and the Zenodo file checksum; the three HTML sources were refetched and all three hashes matched. The report prints no tables, so npm run batch -- check-values cannot place any locator and reports locator_not_parsed for all 101 results; value-check.tsv is kept as that record. All 101 were therefore re-read by review/check_figure_labels.py, written for this pass and using neither of the extractor's scripts: it reads the word-level geometry of a pdftotext -bbox-layout run and places every cell by its x and y coordinates, so each value is tied to the row whose label it sits beside and to the column or panel whose printed header it sits under, rather than to a line of a -layout text layer or a character offset. Figure 2's three panels and Figure 17's two columns were resolved by clustering the value positions and ordering the clusters by the printed headers; every printed 95% interval was matched to the result's uncertainty bounds. 113 checks, no disagreement. Three arithmetic constraints were re-derived: Figure 17's five per-lineage Pearson r values average to the bottom chart's overall r for both Ladon (0.872 against a printed 0.87) and CIBERSORT (0.594 against 0.600), which independently fixes which of the two numbers in each lineage label is Ladon's; Figure 2's pan-cancer bar differs from the mean of its two transfer bars, as the caption requires; and Figure 14's in-figure top-5% label agrees with the page 27 prose. A manual sample was read by eye from the -layout text layer: all 24 Figure 2 cells, all 14 Figure 3 OS and PFS values, all 10 Figure 18 AUCs with their intervals, and the Figure 5, 11, 12a, 13 and 17 readouts, with column and panel assignment checked in each. Figure 2's 24 cells, Figure 3's 14 and Figure 18's 10 AUCs and intervals were confirmed a third time against the facet and row keys of the authors' own figure pages.; note: Printed label re-read from the pinned PDF by coordinates; it matched.; retrieval url: https://zenodo.org/api/records/24157116/files/Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf/content; reviewed at: 2026-11-15T23:30:00Z; reviewer: claude; reviewer note: Claude review agent, independent of the extractor; no human review claimed. Transcription was checked against the pinned sources, which is not reproduction: nothing was rerun and no value was recomputed.
- source locator
- Figure 3 (page 7), row 'TPM · matched TCGA', label 'PFS 1.33'
- unit
- unitless